Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Camel-IDS NV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10991
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies coupled with radioisotope to kill cancer cells. The company offers pipeline products through various compounds and product formulations. Its products provide delivery of therapeutic radiation to cancer cells, while sparing healthy tissues. The company works in collaborations with clinical research institutions and organizations. Camel-IDS is headquartered in Brussels, Belgium.

Camel-IDS NV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Camel-IDS NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Camel-IDS NV, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Camel-IDS Raises USD41.8 Million in Series A Financing 10
Camel-IDS Raises USD1.5 Million in Seed Financing 12
Camel-IDS Plans to Raise USD7 Million in Series A Financing 13
Licensing Agreements 14
Camel-IDS Enters into Licensing Agreement with Vrije Universiteit Brussel 14
Camel-IDS NV – Key Competitors 15
Camel-IDS NV – Key Employees 16
Camel-IDS NV – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Camel-IDS NV, Pharmaceuticals & Healthcare, Key Facts 2
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Camel-IDS NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Camel-IDS NV, Deals By Therapy Area, 2012 to YTD 2018 8
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Camel-IDS Raises USD41.8 Million in Series A Financing 10
Camel-IDS Raises USD1.5 Million in Seed Financing 12
Camel-IDS Plans to Raise USD7 Million in Series A Financing 13
Camel-IDS Enters into Licensing Agreement with Vrije Universiteit Brussel 14
Camel-IDS NV, Key Competitors 15
Camel-IDS NV, Key Employees 16

List of Figures
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Camel-IDS NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Neos Therapeutics Inc (NEOS):企業の財務・戦略的SWOT分析
    Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Regeneron Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • E.ON UK Plc:企業の戦略的SWOT分析
    E.ON UK Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kongsberg Maritime AS:企業の戦略的SWOT分析
    Kongsberg Maritime AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • LeasePlan Corporation N.V.:企業の戦略・SWOT・財務情報
    LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report Summary LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zeltiq Aesthetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • Voltamp Transformers Ltd (VOLTAMP):企業の財務・戦略的SWOT分析
    Voltamp Transformers Ltd (VOLTAMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Scb Life Assurance Public Company Limited:企業の戦略・SWOT・財務分析
    Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Scb Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • CIMB Private Banking:企業の戦略・SWOT・財務分析
    CIMB Private Banking - Strategy, SWOT and Corporate Finance Report Summary CIMB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Chorus Aviation Inc.:戦略・SWOT・企業財務分析
    Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report Summary Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Softrock Minerals Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Softrock Minerals Ltd (Softrock Minerals), formerly Petromax Resources Inc is an oil and gas exploration and development company. The company acquires, explores and develops oil and gas, and mineral deposits. It holds oil and gas producing interests in Alberta. Softrock Minerals also holds m …
  • Brodrene Hartmann A/S:企業の戦略・SWOT・財務情報
    Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report Summary Brodrene Hartmann A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HTG Molecular Diagnostics Inc (HTGM):医療機器:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • ITC Holdings Corp.:電力:M&Aディール及び事業提携情報
    Summary ITC Holdings Corp. (ITC Holdings), an indirect subsidiary of Fortis Inc, is an independent electricity transmission company. It owns, operates, maintains, and invests in transmission infrastructure. The company harnesses system integrity and reliability, reduces transmission constraints, all …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • GGP Inc:戦略・SWOT・企業財務分析
    GGP Inc - Strategy, SWOT and Corporate Finance Report Summary GGP Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Invictus Oncology Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Invictus Oncology Pvt Ltd (Invictus Oncology) is a biopharmaceutical company with focus on the discovery, development and commercialization of anti-cancer drugs. The company develops platinum-based drugs to treat various types of cancers. It engineers platinum-based drugs harnessing structur …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆